Medical Management With Endovascular Thrombectomy Versus Medical Management Alone in Patients Presenting Beyond 24 Hours of Last Known Well

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-85
SponsorAmrou Sarraj

About this trial

SELECT LATE trial aims to evaluate if addition of endovascular thrombectomy to medical management in patients presenting with acute ischemic stroke and a proximal large vessel occlusion in the anterior circulation between 24 and 72 hours of stroke onset results in achieving better functional outcomes (measured using modified Rankin Scale Scores) at 90-day follow-up (± 15 days).

Eligibility criteria

Qualifiers

Adults (18-85* years) with the final diagnosis of an acute ischemic stroke$

NIHSS ≥ 6

Time from last-known-well to randomization >24 - 72 hours

Pre-stroke modified Rankin Scale score of 0-1

Disqualifiers

Current participation in another investigational interventional drug or device study.

Baseline Platelet count <100,000/μl

Proven large vessel occlusion in ICA or MCA-M1 occlusion (carotid occlusions can be cervical or intracranial, with or without tandem MCA lesions), as determined by MR Angiography (MRA) or CT Angiography (CTA)

CT ASPECTS 3-10

Trial design

Treatments tested in this trial

  • Endovascular Thrombectomy
  • Medical Management

Treatment groups

408 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Amrou Sarraj

Lead sponsor

University Hospitals Cleveland Medical Center

Sponsor institution

Patient-Centered Outcomes Research Institute

Collaborator